SHELBY HOOPER: Open Payments
NPI 1639811326 · LAWRENCEBURG, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$750 in 48 payments from 13 companies in 2025. Trend: 2023 $99 · 2024 $452 · 2025 $750
Food & beverage: $750
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $188 |
| AstraZeneca Pharmaceuticals LP | 6 | $147 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $58 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Vanda Pharmaceuticals Inc. | 2 | $53 |
| Viatris Specialty LLC | 3 | $45 |
| Insulet Corporation | 2 | $40 |
| PFIZER INC. | 2 | $34 |
| Corcept Therapeutics | 2 | $33 |
| Novo Nordisk Inc | 2 | $33 |
Products named: VRAYLAR, AIRSUPRA, CAPLYTA, TRELEGY ELLIPTA, HETLIOZ, YUPELRI, Omnipod, NURTEC ODT.
Industry payments across TN — which companies pay providers there.
